Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,66 USD | 0,00% | +3,79% | -25,68% |
Métier
Nombre d'employés: 136
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 14 | 100,0 % | - |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
John Tucker
CEO | Chief Executive Officer | 61 | 01/01/17 |
Rachael Nokes
DFI | Director of Finance/CFO | 49 | 01/09/14 |
John Mohr
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/17 |
Mike Hassman
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/18 |
Investor Relations Contact | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 78 | 01/01/14 | |
Klaus Veitinger
BRD | Director/Board Member | 62 | 21/11/17 |
John Tucker
CEO | Chief Executive Officer | 61 | 01/01/17 |
Frederick Hudson
BRD | Director/Board Member | 78 | 19/06/18 |
William Abraham
BRD | Director/Board Member | 64 | 16/02/21 |
Jack Khattar
CHM | Chairman | 62 | 12/07/16 |
Mette Agger
BRD | Director/Board Member | 59 | 01/03/14 |
Director/Board Member | 76 | 24/07/18 | |
Sara Bonstein
BRD | Director/Board Member | 43 | 08/07/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 36 054 409 | 29 518 053 ( 81,87 %) | 0 | 81,87 % |
Coordonnées société
scPharmaceuticals, Inc.
25 Burlington Mall Road Suite 203
01830, Burlington
+617 517 0730
http://www.scpharmaceuticals.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-25,68% | 168 M | |
+26,08% | 662 Md | |
+21,85% | 546 Md | |
-4,77% | 359 Md | |
+16,97% | 323 Md | |
+5,69% | 290 Md | |
+13,68% | 234 Md | |
+3,65% | 198 Md | |
-11,12% | 194 Md | |
-3,40% | 157 Md |
- Bourse
- Actions
- Action SCPH
- Société scPharmaceuticals Inc.